<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347837">
  <stage>Registered</stage>
  <submitdate>8/12/2011</submitdate>
  <approvaldate>12/12/2011</approvaldate>
  <actrnumber>ACTRN12611001271998</actrnumber>
  <trial_identification>
    <studytitle>The Impact of Micronutrients on Gene Expression in Prostate Cancer: Lycopene</studytitle>
    <scientifictitle>The Impact of Micronutrients on Gene Expression in Prostate Cancer: Lycopene</scientifictitle>
    <utrn>U1111-1126-3180</utrn>
    <trialacronym>ImoGEX(TM)-PC-Lyc</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Prostate cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Prostate</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Lycopene - oral supplement 3 times daily - 15-90mg for 6-10 weeks; differs on a case-by-case basis as determined by clinician</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Global gene expression via blood and tissue analysis</outcome>
      <timepoint>Baseline - post-prostatectomy</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>A range of markers measured using blood analysis, including: full blood count, PSA, lipids, IGF-1, IGFBP3</outcome>
      <timepoint>Baseline - post-prostatectomy</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>(1)	Age 35-80 years
(2)	Non-smoker
(3)	Patients with a diagnosis of clinically localised prostate cancer who are scheduled to undergo radical prostatectomy in 6-8 weeks
(4)	Normal liver function tests, as verification that the tumour is localized to the prostate gland</inclusivecriteria>
    <inclusiveminage>35</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>(1)	No diagnosis of prostate cancer
(2)	Body mass index &lt;18.5kg/m2 (underweight) or &gt;35kg/m2 (obese  class II)
(3)	Current infection
(4)	Prior therapy for prostate cancer (e.g. chemotherapy; radiation therapy; hormonal therapy)
(5)	Current consumption of testosterone replacement medicines
(6)	Current consumption of 5-alpha-reductase inhibitors 
(7)	Consumption of other herbal or nutritional supplements, apart from a single multi-vitamin tablet 
(8)	Inability to provide informed consent due to diminished understanding or comprehension, or a language other than English spoken and an interpreter unavailable</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>All patients receive the treatment</concealment>
    <sequence>All patients receive the treatment</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>Patients serve as their own control</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1 / Phase 2</phase>
    <anticipatedstartdate>1/02/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>24</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Queensland</primarysponsorname>
    <primarysponsoraddress>St Lucia
Brisbane QLD 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Sanofi Aventis Prostate Cancer Research Award</fundingname>
      <fundingaddress>Clinical Oncological Society of Australia
Level 1, 120 Chalmers Street
Surry Hills NSW 2010</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress>Nil</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Other Collaborative groups</othercollaboratortype>
      <othercollaboratorname>Mater Medical Research Institute</othercollaboratorname>
      <othercollaboratoraddress>Level 3, Aubigny Place
Raymond Terrace
South Brisbane QLD 4101</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Diamantina Institute, The University of Queensland</othercollaboratorname>
      <othercollaboratoraddress>R-Wing
Princess Alexandra Hospital
Ipswich Road, Woolloongabba QLD 4102</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other Collaborative groups</othercollaboratortype>
      <othercollaboratorname>Translational Research Institute</othercollaboratorname>
      <othercollaboratoraddress>Princess Alexandra Hospital
Ipswich Road, Woolloongabba QLD 4102</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to conduct a small, translational research trial in a group of men with prostate cancer, to determine the whole-genome effects of lycopene supplementation.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Nil</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Greenslopes Private Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Greenslopes Private Hospital
Newdgate Street
Greenslopes QLD 4120</ethicaddress>
      <ethicapprovaldate>21/09/2011</ethicapprovaldate>
      <hrec>11/40</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Mater Health Services Human Research Ethics Committee</ethicname>
      <ethicaddress>Mater Misericordiae Health Services Brisbane Ltd
Raymond Terrace South
Brisbane QLD 4101</ethicaddress>
      <ethicapprovaldate />
      <hrec>1839P</hrec>
      <ethicsubmitdate>6/09/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Olivia Wright</name>
      <address>School of Human Movement Studies
Level 5, Connell Building
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 7768</phone>
      <fax>+61 7 3365 6877</fax>
      <email>o.wright@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Olivia Wright</name>
      <address>School of Human Movement Studies
Level 5, Connell Building
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 7768</phone>
      <fax>+61 7 3365 6877</fax>
      <email>o.wright@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Olivia Wright</name>
      <address>School of Human Movement Studies
Level 5, Connell Building
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 7768</phone>
      <fax>+61 7 3365 6877</fax>
      <email>o.wright@uq.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>